Mammography

An aggressive, stealthy small breast cancer sub-type accounts for 10 percent of all breast cancers but half of all lesion-related deaths.

Preliminary results from American College of Radiology Imaging Network Trial 6657 show that MRI estimates residual breast cancer disease area better than clinical exams or mammography.

PET niche developer Naviscan arrived at the RSNA meeting with permission from the FDA to launch its Stereo Navigator, a biopsy guidance feature for its breast-specific PET scanner. Stereo Navigator can localize lesions as small as 2 mm. It uses a stereotactic frame fixed between the scanner’s paddles to guide a biopsy needle into the breast. Localization is verified using a PET-visible line source inserted into the needle track. This allows the user to confirm trajectory and position. The PET-guidance accessory is compatible with biopsy devices from Ethicon Endo-Surgery, Hologic, and SenoRx.

Enhancements in breast imaging mark the latest ultrasound upgrade from Philips Healthcare. Tissue aberration correction technology and algorithms built into the Vision 2009 upgrade for its iU22 radiological flagship are part of an integrated effort to better define tissue in fatty breasts, according to the company. An enabling technology is the Philips PureWave transducer and its coded beamformer, which have been present on earlier technologies.

RSNA newcomer readies breast ultrasoundVital Images launches workstation for webZiosoft allies with MedicsightMerge expands support, OEM offeringsMammo digitizer prepares for RSNA 2008Visage pairs with Viatronix

Themes emerging from breast imaging abstracts at the upcoming RSNA include the increased use of breast MRI, full-field digital mammography versus film-screen mammography, and more.

Computer-aided detection significantly improves the sensitivity of pulmonary embolism imaging, according to a study that will be presented at the 2008 RSNA meeting. Other studies show that specially developed CAD schemes can detect flat lesions that are often missed in CT colonography.

Computer-aided detection is gradually gaining acceptance in radiology and has become a major research focus in the past few years. The development of CAD with multislice CT has reached the point where, together, they have the potential to offer new capabilities in the interpretation of emergency room scans.

It’s been a long time coming. Nearly a decade has passed since ATL took a serious run at advancing the medical art of breast cancer diagnosis. The company, long-since absorbed by Philips Healthcare, developed a novel algorithm designed for its Ultramark 9 HDI, later adapted for its HDI 3000 and 5000.

Full-field digital mammography was built on solid-state technology.The first such machines, introduced eight years ago,were based on flat-panel detectors, a tradition that continueduntil the commercial introduction of computed radiography afew years ago.

Ultrasound will step into thepolitically charged environs ofwomen's health and address thevagaries of today's financial challengesat this year's RSNA meeting.

iCAD debuts MR breast and prostate packagesGE upgrades cardiovascular systemsLaser mammo system heads for HungaryFujifilm lands Amerinet contract

Boom continues in breast MR Merge sees light at tunnel’s endBarco updates 3D part of Fuji PACSIsrael buys CT laser mammo

InSite One lands VHA contractRAS offers online mammo scheduling

Findings from a large study by British researchers suggest mammography screening interpretations by a single radiologist using computer-aided detection are just as good as double reads and could yield better cancer detection rates than single reads without CAD. Despite higher recall rates, single reads with CAD could offer staffing costs trade-offs.

DRA cuts prove three times worse than expectedNEMA releases animal PET standardCarestream taps into mobile devicesHologic readies breast density tool for market

Tomographic ultrasound imaging on 4D volumes of fetal chest obtained with spatiotemporal image correlation and color Doppler shows good retrieval of diagnostic cardiac planes in fetuses with ventricular septal defects, according to an Italian study.

Throughout its 30-year history, Diagnostic Imaging has tracked issues surrounding the adoption and development of new imaging technology. Rarely, however, have we looked closely at the question of the learning curves associated with this new technology. This month marks an exception. Our cover story on digital mammography recall rates (page 30) explores why some facilities may be seeing a jump, albeit temporary, in digital mammography recalls and suggests some solutions for keeping those rates down.

Breast cancer is the most common malignancy in adult women. One woman in 11 will contract the disease during her lifetime. The primary goal of treatment is cure, through surgery either alone or in combination with radiotherapy and/or chemotherapy. Surgical management options include breast conservation, mastectomy, and palliative treatment.

As imaging centers convert their workflow to capitalize on the benefits of digital mammography, some radiologists are concerned about the possibility of an increase in the number of patients recalled. Discrepancies between prior screen-film exams and current digital images lead many radiologists to act "better safe than sorry" in their diagnostic interpretation of full-field digital mammography images.

Breast cancer is the most common malignancy in adult women. One woman in 11 will contract the disease during her lifetime. The primary goal of treatment is cure, through surgery either alone or in combination with radiotherapy and/or chemotherapy. Surgical management options include breast conservation, mastectomy, and palliative treatment.

Amicas revs upiCAD cruises to record 2QNeoprobe revenues riseVital launches CME efforts

A recent advisory by the FDA urging breast imaging facilities to ensure compatibility between full-field digital mammography systems and PACS exposed an ongoing problem: Interoperability issues persist as some vendors fail to comply with healthcare digital imaging standards.

FDG-PET/CT's power for staging and restaging breast cancer is attracting attention. It could also detect recurrence in more than two-thirds of these patients and change the management plan in up to a third, according to German investigators.

The FDA is considering a national registry for thermal ablation treatment of breast cancer. The proposed registry would compile information on all thermal ablation devices and therapies for small carcinomas and address inconsistencies that potentially diminish the value of previously published feasibility protocols.

PACS may obscure FFDM dataSiemens reports 3Q growthVelocity updates treatment planningItaly sets CT colonography project

Women with diagnostic mammograms flagged as probably benign usually undergo short-interval follow-up. But at 12 months, this second look may not boost cancer detection.

It is a safe bet that conventional mammography will give way to 3D imaging and other advanced technologies in the not-too-distant future. The gamble lies in picking which technology will emerge the clear winner as the primary screening tool for breast cancer: digital breast tomosynthesis or dedicated breast CT.

Now that computer-aided detection has become part of routine clinical work for cancer screening in mammograms and is being applied in the differential diagnosis of cancer in the lung and colon, it's only a matter of time before it rates as the standard of care for diagnostic examinations in daily clinical work.